Trials / Conditions / Neurocysticercosis

Neurocysticercosis

17 registered clinical trials studyying Neurocysticercosis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis NCT07208656	Cephas Health Research Initiative Inc, Ibadan, Nigeria	N/A
Not Yet Recruiting	Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocyst NCT06376396	R-Evolution Worldwide S.r.l. Impresa Sociale	Phase 4
Unknown	Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study NCT04706819	All India Institute of Medical Sciences	—
Completed	Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia NCT03874689	Technical University of Munich	—
Completed	Treatment of Patients With Active Neurocysticercosis in Eastern Africa NCT03834337	Technical University of Munich	—
Completed	The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania NCT03851419	Technical University of Munich	—
Terminated	Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) NCT02947581	Universidad Peruana Cayetano Heredia	Phase 3
Terminated	Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) NCT02945527	Universidad Peruana Cayetano Heredia	Phase 2 / Phase 3
Completed	Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole NCT02234570	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Terminated	People Presenting With Neurocysticercosis in North America NCT02233855	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesion NCT02243644	All India Institute of Medical Sciences	Phase 3
Completed	Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) NCT00441285	Universidad Peruana Cayetano Heredia	Phase 2 / Phase 3
Completed	PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB NCT00527579	National Institute of Mental Health (NIMH)	Phase 1
Completed	PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 NCT00526916	National Institute of Mental Health (NIMH)	Phase 1
Completed	Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients NCT00290823	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3
Completed	A Pilot Study of Neurocysticercosis Treatment NCT00283699	Columbia University	Phase 3
Recruiting	Natural History of Treated Neurocysticercosis and Long-Term Outcomes NCT00001205	National Institute of Allergy and Infectious Diseases (NIAID)	—